Medicare Enrolled
Dr. Habte Yimer, M.D.
Hematology · Tyler, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yimer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yimer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yimer
Dr. Habte Yimer is a hematology specialist in Tyler, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yimer performed 133,638 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Yimer received a total of $827,252 from 74 pharmaceutical and/or device companies across 992 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yimer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in TX
$827,252 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗133,638
Medicare services
Top 3% in TX for hematology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
20,910 | $0 | $5 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
18,560 | $0 | $33 |
| Nivolumab injection (Opdivo) | 12,460 | $23 | $76 |
| Pembrolizumab injection (Keytruda) | 12,200 | $42 | $136 |
| Paclitaxel chemotherapy injection | 9,582 | $0 | $8 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
9,254 | $0 | $3 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,345 | $2 | $20 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
7,100 | $0 | $2 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
5,940 | $38 | $127 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,093 | $0 | $1 |
| Injection, atropine sulfate, 0.01 mg | 2,640 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 2,160 | $18 | $66 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
1,970 | $24 | $155 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
1,930 | $34 | $233 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,731 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,519 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,227 | $10 | $64 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,033 | $6 | $31 |
| Injection, granisetron hydrochloride, 100 mcg | 1,030 | $0 | $24 |
| Injection, leucovorin calcium, per 50 mg | 798 | $3 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
742 | $91 | $368 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
732 | $9 | $56 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
679 | $11 | $108 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
609 | $2 | $13 |
| Anti-nausea injection (Aloxi/palonosetron) | 540 | $1 | $114 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
468 | $96 | $707 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
360 | $2 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
349 | $60 | $250 |
| Injection, potassium chloride, per 2 meq | 330 | $0 | $1 |
| Injection, irinotecan, 20 mg | 295 | $2 | $210 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
271 | $6 | $431 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
236 | $2 | $94 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
228 | $8 | $49 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
219 | $22 | $157 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 216 | $3 | $373 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
187 | $13 | $60 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
185 | $271 | $2,762 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
174 | $46 | $313 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
168 | $80 | $1,348 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
160 | $48 | $344 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
160 | $70 | $70 |
| Iron level test | 156 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
156 | $9 | $35 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
140 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
140 | $6 | $34 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
140 | $1 | $6 |
| Gemcitabine chemotherapy injection, 200 mg An injection of gemcitabine hydrochloride, a chemotherapy medication, administered in a 200 mg dose. |
140 | $3 | $28 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
137 | $21 | $161 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 125 | $344 | $1,722 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
123 | $35 | $143 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
122 | $1 | $7 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
113 | $10 | $96 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
109 | $7 | $29 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
98 | $55 | $211 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
87 | $48 | $821 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
73 | $1 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
71 | $2 | $19 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
63 | $15 | $94 |
| New patient office visit, complex (60-74 min) | 63 | $156 | $709 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
60 | $164 | $1,067 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
60 | $15 | $76 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
58 | $124 | $500 |
| PSA test (prostate cancer screening) | 48 | $18 | $94 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
46 | $16 | $100 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 46 | $91 | $657 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
44 | $19 | $99 |
| Radiation therapy, 3+ areas, 11-19 MeV Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators. |
42 | $178 | $700 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
39 | $16 | $114 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
36 | $1,101 | $4,802 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
35 | $40 | $289 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
28 | $61 | $247 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
26 | $1 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $24 | $256 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
22 | $4 | $24 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $10 | $75 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
21 | $4 | $26 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
21 | $24 | $145 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
21 | $53 | $264 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
19 | $5 | $31 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
18 | $40 | $686 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
17 | $190 | $1,413 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
14 | $74 | $560 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
14 | $14 | $96 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $133 | $694 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
18.0% high complexity
75.1% medium
6.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$827,252
Total received (2018-2024)
Avg $118,179/year across 7 years
Top 2% in TX for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
992
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$122,659
2023
$141,512
2022
$116,510
2021
$115,278
2020
$92,725
2019
$127,126
2018
$111,442
Payments by company (2024)
ABBVIE INC.
$25,413
PFIZER INC.
$24,581
Janssen Biotech, Inc.
$16,018
Genmab U.S., Inc.
$14,209
Karyopharm Therapeutics Inc.
$10,954
BeiGene USA, Inc.
$10,764
Amgen Inc.
$9,831
Incyte Corporation
$3,322
E.R. Squibb & Sons, L.L.C.
$2,306
AstraZeneca Pharmaceuticals LP
$2,073
Lilly USA, LLC
$1,462
Celgene Corporation
$329
Regeneron Healthcare Solutions, Inc.
$194
GlaxoSmithKline, LLC.
$182
ADC Therapeutics America, Inc.
$180
Tempus AI, Inc
$157
Daiichi Sankyo Inc.
$140
Alexion Pharmaceuticals, Inc.
$102
Blueprint Medicines Corporation
$90
GENZYME CORPORATION
$79
SOBI, INC
$73
Stemline Therapeutics Inc.
$45
Astellas Pharma US Inc
$37
Pharmacosmos Therapeutics Inc.
$24
ARRAY BIOPHARMA INC
$21
JAZZ PHARMACEUTICALS INC.
$21
Merck Sharp & Dohme LLC
$21
Novartis Pharmaceuticals Corporation
$16
PUMA BIOTECHNOLOGY, INC.
$13
Top 3 companies account for 53.8% of 2024 payments
All-time payments by company (2018-2024) ›
BeiGene USA, Inc.
$139,615
Janssen Biotech, Inc.
$134,818
AstraZeneca Pharmaceuticals LP
$130,326
Amgen Inc.
$63,492
Karyopharm Therapeutics Inc.
$54,870
Takeda Pharmaceuticals U.S.A., Inc.
$46,791
Janssen Scientific Affairs, LLC
$35,490
ABBVIE INC.
$32,596
PFIZER INC.
$26,797
Lilly USA, LLC
$22,038
GlaxoSmithKline, LLC.
$21,850
Genmab U.S., Inc.
$20,631
AbbVie Inc.
$15,127
Seattle Genetics, Inc.
$9,876
Celgene Corporation
$9,158
Epizyme, Inc.,
$6,658
Incyte Corporation
$5,732
E.R. Squibb & Sons, L.L.C.
$5,728
GENZYME CORPORATION
$4,980
Genentech, Inc.
$4,162
Adaptive Biotechnologies Corporation
$4,145
Novartis Pharmaceuticals Corporation
$3,785
ADC Therapeutics America, Inc.
$2,977
BeiGene, Ltd.
$2,650
TAIHO ONCOLOGY, INC.
$2,343
Heron Therapeutics, Inc.
$2,240
Ipsen Biopharmaceuticals, Inc
$2,126
F. Hoffmann-La Roche AG
$2,052
Pharmacyclics LLC, An AbbVie Company
$1,945
MorphoSys, US Inc.
$1,770
CTI BioPharma Corp.
$1,757
Seagen Inc.
$1,481
Novocure Inc.
$1,272
Aadi Bioscience, Inc.
$1,000
G1 Therapeutics, Inc.
$893
Genentech USA, Inc.
$504
Regeneron Healthcare Solutions, Inc.
$276
Astellas Pharma US Inc
$249
Kite Pharma, Inc.
$248
Puma Biotechnology, Inc.
$246
Blueprint Medicines Corporation
$206
AbbVie, Inc.
$202
Merck Sharp & Dohme Corporation
$184
Tempus AI, Inc
$157
Exelixis Inc.
$141
Daiichi Sankyo Inc.
$140
Clovis Oncology, Inc.
$125
SOBI, INC
$123
Eisai Inc.
$119
Mirati Therapeutics, Inc.
$117
Rigel Pharmaceuticals, Inc.
$107
Synergy Pharmaceuticals Inc
$106
Alexion Pharmaceuticals, Inc.
$102
Bayer HealthCare Pharmaceuticals Inc.
$95
Stemline Therapeutics Inc.
$94
TESARO, Inc.
$73
JAZZ PHARMACEUTICALS INC.
$64
Gilead Sciences, Inc.
$51
ARRAY BIOPHARMA INC
$46
Boston Scientific Corporation
$33
Immunocore Limited
$29
Tactile Systems Technology Inc
$27
Pharmacosmos Therapeutics Inc.
$24
Sun Pharmaceutical Industries Inc.
$24
EMD Serono, Inc.
$22
Merck Sharp & Dohme LLC
$21
Pharmacyclics LLC, an AbbVie Company
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
Sumitomo Pharma America, Inc.
$17
Allergan Inc.
$13
PUMA BIOTECHNOLOGY, INC.
$13
Taiho Oncology, Inc.
$12
Janssen Pharmaceuticals, Inc
$10
Top 3 companies account for 48.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYDUREON · CALQUENCE · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FLEXITOUCH · FYARRO · Fedratinib · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · IMJUDO · INLYTA · INQOVI · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KYMRIAH · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nerlynx · Non-Covered Product · OJJAARA · OPDIVO · ORGOVYX · Orserdu · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · TABRECTA · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tazverik · Trulance · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VYNDAQEL · VYXEOS · Vectibix · Vonjo · WATCHMAN Access System · XALKORI · XPOVIO · XT CDX · XTANDI · Xospata · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
1
County median income
$71,923
Nearest hospital to ZIP centroid (approximate)
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yimer is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yimer experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Yimer performed 20,910 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yimer receive payments from pharmaceutical companies?
Yes. Dr. Yimer received a total of $827,252 from 74 companies across 992 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yimer's costs compare to other hematologists in Tyler?
Dr. Yimer's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yimer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Tyler
Browse hematologists in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in TX
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in TX
Which TX hematologists receive the most from drug and device companies.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology